As largest IPO of year, SK Biopharmaceuticals makes strong market debut
MarketsJul 2, 2020
Prior to its market debut, local and offshore investors rushed for SK Biopharmaceuticals shares due to its growth potential amid the coronavirus pandemic. The retail investors’ tranche marked the end of its IPO to raise 959.3 billion won through 19,578,310 common shares. In the two-day retail tranche that was held on June 23-24, the shares were oversubscribed 323 times with deposit payments amou...